2015
DOI: 10.12688/f1000research.6519.1
|View full text |Cite
|
Sign up to set email alerts
|

It's never too late to publish an abandoned trial

Abstract: It is estimated that half of all trials have never been published which can lead to patients being denied the most effective treatment and being exposed to unnecessary side effects.  Furthermore the trial participants have been misinformed since the trial results have not contributed to the care of future patients.However the non-publication of trials is often not due to a deliberate decision to cover up results.  Commonly in academia it is due to more understandable reasons such as researchers having busy cli… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…Even if our findings are consistent with previously observed rates of non-publication in other clinical scenarios, our results add to existing work by showing that this representation problem is an essential feature of interventional phase 3 and 4 trials in radiation oncology, since studies assessing non-publication did not analyse interventional radiotherapy trials separately. [9][10][11][12][13][14][15][16][17][18][19][20] It is worth noting that trials funded by NIH and industry showed a higher rate of reporting results in the registry than did other trials, even though nearly 65% of NIH-funded and industry-funded trials did not report anything in ClinicalTrials. gov.…”
Section: Discussionmentioning
confidence: 99%
“…Even if our findings are consistent with previously observed rates of non-publication in other clinical scenarios, our results add to existing work by showing that this representation problem is an essential feature of interventional phase 3 and 4 trials in radiation oncology, since studies assessing non-publication did not analyse interventional radiotherapy trials separately. [9][10][11][12][13][14][15][16][17][18][19][20] It is worth noting that trials funded by NIH and industry showed a higher rate of reporting results in the registry than did other trials, even though nearly 65% of NIH-funded and industry-funded trials did not report anything in ClinicalTrials. gov.…”
Section: Discussionmentioning
confidence: 99%